Schizophrenia | Progress In Mind

Home

Aiming for personalized treatment — detecting true-positive subgroups

The ultimate goal for personalized medicine is to prescribe the right treatment for the right...

Satellite symposium

Treatment outcomes in schizophrenia – what matters to patients?

Schizophrenia treatment has moved from mainly addressing relapse prevention and symptom suppression...

What do clinical goals mean to patients with schizophrenia?

Satellite symposium

Are relapse prevention and functioning sufficiently prioritized in the treatment of schizophrenia?

Improving adherence and reducing rates of relapse and rehospitalization are of paramount importance...

Congress highlights

Early psychosis intervention works, but can we move to prevention?

Many individuals at high familial risk of schizophrenia show cognitive and social impairment well...

Congress highlights

Can we be bothered about apathy? Approaching negative symptoms in schizophrenia

There has been an increased interest in research for the negative symptoms of schizophrenia over...

Should we challenge the way we assess functioning?

Congress highlights

Towards a focus on the science in treatment classifications

The nomenclature for psychotropic drugs has not been overhauled for about 60 years, so it has...

Congress highlights

Early intervention for psychosis: Is it worth the investment?

In a session at WFSBP, chaired by Professor Matcheri Keshavan, Harvard Medical School, Boston, MA,...

Early use of a long acting injectable antipsychotic shortens hospital stay for acute schizophrenia

Average hospital stay for patients treated with a long-acting injectable (LAI) antipsychotic...

Patient-reported outcomes — need for more guidance and consistency

Patient-reported outcomes (PROs) are increasingly important for regulators. However, the European...

Bipolar, Schizophrenia

Could therapeutic manipulation of critical periods of brain development benefit mental health?

Many critical periods of brain development occur during infancy and childhood. When these periods...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind South East Asia
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in South East Asia click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline